FindTrial
Sign In

Use of Fentanyl injection for cancer pain in children

Development of intravenous Fentanyl dosing protocol for pain management in paediatric haematolymphoid malignancies - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060396
Enrollment
150
Registered
2023-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with cancer ( >3 to

Exclusion criteria

Exclusion criteria: Children with Cognitive impairment and speech impairment; Solid tumours; Patients who are not willing to participate in the study.; Chronic pain (pain with >3 months persistence or recurrence)

Design outcomes

Primary

MeasureTime frame
Modelling and qualification of a dose-response based pharmacodynamic model that could be a potential/ tool for clinical use in the future.Timepoint: At random time points within 1-4 hours after drug administration.—

Secondary

MeasureTime frame
a. The prescription pattern of Fentanyl in the patients. b. The variables with the highest frequency for Fentanyl usage. c. The cost of illness and its predictors. Timepoint: At a Single time point before discharge.—

Countries

India

Contacts

Public ContactRajesh V

Kasturba Medical College

vasudev.bhat@manipal.edu9619114703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026